Match tier Likely match
Presence Current · Arkansas
Last published 2024
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Arisha Ishtiaq

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

UA Little Rock

Unknown Researcher

2 h-index 3 pubs 16 cited

Research Areas

Biomedical Subjects

  • Photochemotherapy
  • Porphyrins
  • Cations
  • Humans
  • Photosensitizing Agents
  • Nanomedicine

OverviewAI-generated summary

Arisha Ishtiaq's research focuses on developing novel nanomedicine strategies for cancer therapeutics, particularly for combined chemo-phototherapy. Her work investigates the use of ionic nanomedicines, incorporating components like doxorubicin and porphyrins, to enhance treatment efficacy. These ionic nanomedicines are designed to improve the delivery and effectiveness of both chemotherapy and photodynamic therapy in combating cancer. Ishtiaq has published three works in this area since 2023, with a recent focus on doxorubicin-based and cationic porphyrin-based ionic nanomedicines. She has collaborated with researchers at the University of Arkansas at Little Rock, including Noureen Siraj, Mujeebat Bashiru, Mavis Forson, and Nawab Ali, on these publications.

Metrics

  • h-index: 2
  • Publications: 3
  • Citations: 16

Selected Publications

  • IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
    PubMed DOI OpenAlex
  • Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
    ACS Applied Nano Materials 9 citations DOI OpenAlex
  • Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy (2023)
    ACS Applied Bio Materials 7 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

16 Collaborators 6 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics

Nabeel Alwan University of Arkansas at Little Rock
Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Drug Delivery Systems
Good match 4 shared topics
Zachary McConnell University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Drug Delivery Systems
Good match 3 shared topics
Noureen Siraj University of Arkansas at Little Rock
Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Drug Delivery Systems
Good match 4 shared topics
Karthikeyan Chandrabose University of Arkansas for Medical Sciences
Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Drug Delivery Systems
Good match 3 shared topics
Yoshie Sakamaki University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Photochemotherapy
Good match 3 shared topics
David Fugitt University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Drug Delivery Systems
Good match 3 shared topics